This paper reviews current consensus and future possibilities for rhythm control treatment strategies in atrial fibrillation.
Atrial fibrillation (AF) is a disease of ageing, with a prevalence of 3% among people >20 years of age.1,21 Around 10–40% of AF patients are hospitalised annually. Budget-wise, direct AF care consumes 1% of total health spending in the UK.11 AF is the cause of many debilitating conditions
Ahmed Alsunbuli (2020) studied this question.